Clinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Clinical trial NCT01263327 · COMPLETED

Trial details

NCT number: NCT01263327
Sponsor: Xiamen University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2010-12-01
Primary completion: 2011-07-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.